{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T13:25:06Z","timestamp":1776950706257,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012618","name":"NIHR Moorfields Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006400","name":"Alnylam Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006400","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014461","name":"NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust\/Institute of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012617","name":"Moorfields Eye Hospital NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012617","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.oret.2025.03.004","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T21:28:21Z","timestamp":1741814901000},"page":"899-907","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Best Vitelliform Macular Dystrophy Natural History Study Report 2"],"prefix":"10.1016","volume":"9","author":[{"given":"Yannik","family":"Laich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6397-8071","authenticated-orcid":false,"given":"Michalis","family":"Georgiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4248-0033","authenticated-orcid":false,"given":"Kaoru","family":"Fujinami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malena","family":"Daich Varela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7555-5797","authenticated-orcid":false,"given":"Yu","family":"Fujinami-Yokokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaima Awadh","family":"Hashem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7936-6851","authenticated-orcid":false,"given":"Thales A.C.","family":"de Guimaraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1254-0832","authenticated-orcid":false,"given":"Omar A.","family":"Mahroo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6915-9560","authenticated-orcid":false,"given":"Andrew R.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Michaelides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2025.03.004_bib1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/bjophthalmol-2019-315086","article-title":"Macular dystrophies: clinical and imaging features, molecular genetics and therapeutic options","volume":"104","author":"Rahman","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.004_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1601-5223.1974.tb01427.x","article-title":"Hereditary macular degeneration\u2014a population survey in the country of V\u00e4sterbotten, Sweden","volume":"78","author":"Nordstr\u00f6m","year":"1974","journal-title":"Hereditas"},{"key":"10.1016\/j.oret.2025.03.004_bib3","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.ophtha.2017.04.008","article-title":"Clinically focused molecular investigation of 1000 consecutive families with inherited retinal disease","volume":"124","author":"Stone","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.03.004_bib4","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.ophtha.2020.04.008","article-title":"Genetic basis of inherited retinal disease in a molecularly characterized cohort of more than 3000 families from the United Kingdom","volume":"127","author":"Pontikos","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.03.004_bib5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.oret.2024.01.012","article-title":"Spectrum of genetic variants in the most common genes causing inherited retinal disease in a large molecularly characterized United Kingdom cohort","volume":"8","author":"Lin","year":"2024","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2025.03.004_bib6","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ophtha.2024.01.027","article-title":"Best vitelliform macular dystrophy natural history study report 1: clinical features and genetic findings","volume":"131","author":"Laich","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.03.004_bib7","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0161-6420(93)31420-X","article-title":"Visual acuity in patients with Best vitelliform macular dystrophy","volume":"100","author":"Fishman","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.03.004_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1442-9071.1991.tb00665.x","article-title":"Vitelliform dystrophy: long-term observations on New Zealand pedigrees","volume":"19","author":"Clemett","year":"1991","journal-title":"Aust N Z J Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.004_bib9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00006982-200112000-00003","article-title":"Visual outcome following subretinal hemorrhage in Best disease","volume":"21","author":"Chung","year":"2001","journal-title":"Retina"},{"key":"10.1016\/j.oret.2025.03.004_bib10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.oret.2022.11.014","article-title":"Choroidal neovascularization is common in Best vitelliform macular dystrophy and plays a role in vitelliform lesion evolution","volume":"7","author":"Han","year":"2023","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2025.03.004_bib11","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s00417-007-0604-7","article-title":"Choroidal neovascularisation secondary to Best\u2019s disease in a 13-year-old boy treated by intravitreal bevacizumab","volume":"245","author":"Leu","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.004_bib12","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1089\/jop.2011.0250","article-title":"Functional and anatomic changes in bilateral choroidal neovascularization associated with vitelliform macular dystrophy after intravitreal bevacizumab","volume":"28","author":"Cennamo","year":"2012","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.oret.2025.03.004_bib13","doi-asserted-by":"crossref","first-page":"677","DOI":"10.5301\/ejo.5000095","article-title":"Intravitreal bevacizumab for choroidal neovascularization secondary to Best vitelliform macular dystrophy in a 6-year-old child","volume":"22","author":"Chhablani","year":"2012","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.004_bib14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1080\/13816810.2020.1786844","article-title":"Optical coherence tomography angiography cyclic remodeling of CNV in patients affected by Best macular dystrophy","volume":"41","author":"Murro","year":"2020","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.oret.2025.03.004_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.21037\/aes-20-81","article-title":"Retinal imaging in inherited retinal diseases","volume":"5","author":"Georgiou","year":"2020","journal-title":"Ann Eye Sci"},{"key":"10.1016\/j.oret.2025.03.004_bib16","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1136\/bjophthalmol-2021-319228","article-title":"Structural evaluation in inherited retinal diseases","volume":"105","author":"Daich Varela","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.004_bib17","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1055\/s-2003-812555","article-title":"Fundus autofluorescence imaging in Best\u2019s vitelliform dystrophy","volume":"220","author":"Jarc-Vidmar","year":"2003","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.oret.2025.03.004_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2021-000860","article-title":"Correlation of features on OCT with visual acuity and Gass lesion type in Best vitelliform macular dystrophy","volume":"6","author":"Coussa","year":"2021","journal-title":"BMJ Open Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.004_bib19","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.ajo.2014.07.026","article-title":"Fundus autofluorescence patterns in Best vitelliform macular dystrophy","volume":"158","author":"Parodi","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.004_bib20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.oret.2025.03.004_bib21","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/humu.23626","article-title":"Recommendations for interpreting the loss of function PVS1 ACMG\/AMP variant criterion","volume":"39","author":"Abou Tayoun","year":"2018","journal-title":"Hum Mutat"},{"key":"10.1016\/j.oret.2025.03.004_bib22","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s00417-018-4120-8","article-title":"Fibrotic pillar leads to focal choroidal excavation in Best vitelliform dystrophy","volume":"256","author":"Kumar","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.004_bib23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/ICB.0b013e3181babe7e","article-title":"Cup-shaped choroidal excavation detected by optical coherence tomography: a case report","volume":"4","author":"Abe","year":"2010","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.oret.2025.03.004_bib24","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1001\/archophthalmol.2011.148","article-title":"The expanded spectrum of focal choroidal excavation","volume":"129","author":"Margolis","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.004_bib25","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/IAE.0000000000001634","article-title":"Spectral domain optical coherence tomography features in different stages of Best vitelliform macular dystrophy","volume":"38","author":"Battaglia","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.oret.2025.03.004_bib26","doi-asserted-by":"crossref","first-page":"e847","DOI":"10.1111\/aos.14958","article-title":"Disease expression caused by different variants in the BEST1 gene: genotype and phenotype findings in bestrophinopathies","volume":"100","author":"Nowomiejska","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.004_bib27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ajhg.2020.06.011","article-title":"Human iPSC modeling reveals mutation-specific responses to gene therapy in a genotypically diverse dominant maculopathy","volume":"107","author":"Sinha","year":"2020","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.oret.2025.03.004_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-54892-7","article-title":"Investigation and restoration of BEST1 activity in patient-derived RPEs with dominant mutations","volume":"9","author":"Ji","year":"2019","journal-title":"Sci Rep"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025001034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025001034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T20:00:54Z","timestamp":1772913654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653025001034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2468653025001034"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2025.03.004","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Best Vitelliform Macular Dystrophy Natural History Study Report 2","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2025.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00c2\u00a9 2025 Published by Elsevier Inc. on behalf of American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}